Canada-based POINT Biopharma will establish its first U.S. manufacturing facility in Indianapolis. The company plans to invest more than $25 million to purchase and renovate a 77,000 square foot building on the city’s northwest side. The deal will create more than 100 new jobs by the end of 2024. POINT Biopharma CEO Joe McCann joins us to explain what attracted the company to set up shop in Indiana.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}